Chemed Inventory Turnover Ratio 2010-2025 | CHE

Current and historical inventory turnover ratio for Chemed (CHE) from 2010 to 2025. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period. Chemed inventory turnover ratio for the three months ending March 31, 2025 was 55.27.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.183B $2.431B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.852B 19.56
Encompass Health (EHC) United States $12.317B 26.11
DaVita (DVA) United States $10.696B 15.04
Elanco Animal Health (ELAN) United States $7.097B 15.20
Option Care Health (OPCH) United States $5.281B 23.54
RadNet (RDNT) United States $4.286B 272.00
Amedisys (AMED) United States $3.214B 21.62
Addus HomeCare (ADUS) United States $2.118B 23.26
LifeStance Health (LFST) United States $2.003B 0.00
Astrana Health (ASTH) United States $1.386B 34.35
U.S Physical Therapy (USPH) United States $1.201B 30.99
Pennant (PNTG) United States $1.027B 37.72
Aveanna Healthcare Holdings (AVAH) United States $0.979B 55.78
Atai Life Sciences (ATAI) Germany $0.441B 0.00
Daxor (DXR) United States $0.044B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.038B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00